The use of rivaroxaban in patients with antiphospholipid syndrome: A series of 12 cases

Thromb Res. 2015 May;135(5):1035-6. doi: 10.1016/j.thromres.2015.01.028. Epub 2015 Feb 2.

Authors

Maksim Son¹, Ewa Wypasek², Magdalena Celinska-Lowenhoff³, Anetta Undas⁴

Affiliations

¹ Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland.
² Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland; John Paul II Hospital, Cracow, Poland.
³ Department of Medicine, Jagiellonian University Medical College, Cracow, Poland.
⁴ Institute of Cardiology, Jagiellonian University Medical College, Cracow, Poland; John Paul II Hospital, Cracow, Poland. Electronic address: mmundas@cyf-kr.edu.pl.

PMID: 25669601
DOI: 10.1016/j.thromres.2015.01.028

No abstract available

Publication types

Case Reports
Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Anticoagulants / therapeutic use*
Antiphospholipid Syndrome / complications
Antiphospholipid Syndrome / drug therapy*
Antiphospholipid Syndrome / immunology
Female
Humans
Lupus Erythematosus, Systemic / complications
Lupus Erythematosus, Systemic / drug therapy
Lupus Erythematosus, Systemic / immunology
Male
Middle Aged
Pregnancy
Pregnancy Complications / drug therapy
Pregnancy Complications / immunology
Rivaroxaban / therapeutic use*
Secondary Prevention
Venous Thromboembolism / prevention & control
Warfarin / therapeutic use
Young Adult

Substances

Anticoagulants
Warfarin
Rivaroxaban